Effect of individualized homoeopathic medicines in the cases of metabolic syndrome among adult population- a prospective pre-post clinical study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 47
- 试验地点
- 2
- 主要终点
- Changes will be observed in MSSS scale.
研究概览
简要总结
This prospective observational study aims to evaluate the effect of individualized homoeopathic medicines in the centesimal and L M potency in the cases of Metabolic syndrome. Primary outcome is to assess the change in MSSS scale at baseline at 3rd months at the 6th months. The result will be concluded accordingly. study duration is 15 months. sample size will be 47.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 54.00 Year(s)（—）
- 性别
- All
入选标准
- •Participants in the age group between 18 to 54 years and all genders Diagnostic criteria If any 3 conditions of the criteria given below is found in a participant he/she will be included in the study Triglyceride level more than 150 mg/dl (Mild hypertriglyceridemia 150 to 499 mg/dL) HDL level low less than 40 mg/dl Blood pressure more than 130/85 mmHg (stage 1 and stage 2) Fasting blood glucose level more than 120 to 240 mg/dl BMI obesity class1 BMI 30 to 34.9 kg/meter square Participants willing to give consent will be included.
排除标准
- •Participants with other severe systemic illness requiring emergency care and who are immune compromised Pregnant and lactating women Participants who have taken any homoeopathic medicines for last 3 months Participants with any substance use disorder and severe mental disorder.
结局指标
主要结局
Changes will be observed in MSSS scale.
时间窗: 15 months | Enrolment-6 months | Follow up- 6 months | Statistical analysis- 3 months | First dose will be given after case taking. | Subsequent doses as per the follow ups. | MSSS scale will be used at baseline at 3 months and at 6 months.
Changes can be positive or negative or no change.
时间窗: 15 months | Enrolment-6 months | Follow up- 6 months | Statistical analysis- 3 months | First dose will be given after case taking. | Subsequent doses as per the follow ups. | MSSS scale will be used at baseline at 3 months and at 6 months.
次要结局
未报告次要终点
研究者
Dr Farhat Jabeen
Bakson Homoeopathic Medical College and Hospital